Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia.

KP, Dunsmore; SS, Winter; M, Devidas; BL, Wood; N, Esiashvili; Z, Chen; N, Eisenberg; N, Briegel; RJ, Hayashi; JM, Gastier-Foster; AJ, Carroll; NA, Heerema; BL, Asselin; KR, Rabin; PA, Zweidler-Mckay; EA, Raetz; ML, Loh; KR, Schultz; NJ, Winick; WL, Carroll; SP, Hunger

doi:10.1200/jco.20.00256

Public

Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia.

Shared by NobleBlocks on Aug 19, 2020 • 12:00 AM UTC

Authors:

Dunsmore KP

Winter SS

Devidas M

Abstract

Purpose Nelarabine is effective in inducing remission in patients with relapsed and refractory T-cell acute lymphoblastic leukemia (T-ALL) but has not been fully evaluated in those with newly diagnosed disease.Patients and methods From 2007 to 2014, Children's Oncology Group trial AALL0434 (Clinical...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!